Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

5/2/22 aa mCDS Duplicate Alert Change: 5/9/22
May 3, 2022

From: "Aaron Atkins" <aaron.atkins@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Cc: "Karol Jones" <karol.jones@hhsys.org>, "Prabhu Malachi, MD" <prabhu.malachi@hhsys.org>, "Greg Jones" <greg.jones@hhsys.org>, "Cynthia Parker" <cynthia.parker@hhsys.org>
Sent: Monday, May 2, 2022 1:24:23 PM
Subject: mCDS Duplicate Alert Change: 5/9/22

Due to med errors related to duplicate checking/alerting of sodium bicarbonate resulting in removal of product as an additive in IV Sets, effective Monday, May 9, mCDS Duplicate Checking will no longer occur in Powerchart for medications in the categories of ‘antacids’ and ‘electrolytes and minerals’ (listed below) with the exception of Potassium-containing products.   

 

Duplicate alerts for both categories will still occur in MedManager (will display override reason as “mCDS AM” when entered from Powerchart—screenshot below).  Potassium-containing product duplicate alerts will still occur in both Powerchart and MedManager.

 

Please let us know if have any questions prior or if you encounter any issues with this change after implementation.  Thank you.

 






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved